TRIANGLES | July 9, 2020
What's A Drug Worth?
Gilead's (GILD) Remdesivir appears to have been shown to be somewhat effective in the treatment of patients severely affected by Covid-19, which is the disease caused by the coronavirus. This news has had an effect on the share price of the company. The market had been waiting for GILD to set a price for the drug, which they announced last week.
by Stella Osoba, CMT
To continue reading, sign-up for trial access to Traders.com and the S&C Archive — 37,000 pages of trading ideas!
After verifying your email address, you will have limited access to the S&C Archive, as well as access to a Digital Edition of S&C, and access to Traders.com Advantage and Working Money for 30 days.
Log-in now to view articles from the S&C Archive.
Your Subscriber ID is located at the top of your magazine label, highlighted here in red.
Your last name can be found on the second line, highlighted here in blue.
*If you have a company name on the label, that can also be used. It will appear below your name on the label.
If you do not have a Subscriber ID on your label, you can find it on your statement or renewal form.
For help locating your Subscriber ID number, please call us at 1-800-832-4642 or send an email to Survey@Traders.com. If sending an email, please include your name and mailing address.